HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

46.000

-1.940-4.05%

Volume:3.76M

Turnover:174.19M

Market Cap:305.30B

PE:33.42

High:47.940

Open:47.940

Low:45.740

Close:47.940

52wk High:94.869

52wk Low:45.660

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:0.57

T/O Rate:1.46%

Dividend:0.23

Dividend Rate:0.51%

EPS(LYR):1.376

ROE:12.46%

ROA:7.02%

PB:4.06

PE(LYR):33.42

PS:8.36

Loading ...

Overview Company News Filings

Movement Alert｜HENGRUI PHARMA Falls 8.55% in Regular Trading, H1 Revenue Declines as Core Profit Drops 12.7%

Hengrui Pharma Announces Resignation of Joint Company Secretary Liu Xiaohan

Bulletin Express

Hengrui Pharma Appoints Tian Fei as New Board Secretary

HENGRUI PHARMA Proposes New H-Share Incentive Scheme for 2026

Hengrui Pharma Maintains H1 2026 Profitability; Innovative Drug Sales Rise 16.4% Despite Flat Revenue

Bulletin Express

Hengrui Pharma Unveils 2026 A-Share Employee Stock Ownership Plan Valued at Approx. RMB 0.34 Billion

Bulletin Express

Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion

HENGRUI PHARMA: Wellington Management Group LLP Disposes of Shares, Long Position Falls to 5.94%

AH Share Premium Rankings: August 19 Market Close Analysis

Movement Alert｜HENGRUI PHARMA Falls 3.19% in Regular Trading, Cautious Earnings Outlook and Sector Weakness Weigh on Shares

Hengrui Pharma Gets China Nod For Inflammatory Bowel Injection Clinical Trial

MT Newswires Live

Hengrui Pharma Gets China Nod For Phase II Diabetes Drug Trial

MT Newswires Live

Hengrui Pharma Repurchases 0.002% of Share Capital, Adds 0.13 Million Shares to Treasury

Bulletin Express

Hengrui Pharma Spends 6.79 Million Yuan on Share Buyback on August 12

Jiangsu Hengrui Pharma Secures Clinical Trial Approval for Innovative Multi-Peptide Drug HRS-4729 Injection

Earning Preview: HENGRUI PHARMA Q2 revenue is expected to increase, and institutional views are cautiously optimistic

HENGRUI PHARMA: Wellington Management Group LLP Disposes of Shares, Long Position Falls to 6.91%

Hengrui Pharma's NewCo Partner Debuts on Nasdaq Following Kailera

AH Share Premium Ranking Summary for August 10

Hengrui Pharma Gets Nod to Add Fifth Indication for Ivarmacitinib Sulfate Tablets

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/01276/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":46,"timestamp":1788157373098,"preClose":47.94,"halted":0,"volume":3758650,"delay":0,"changeRate":-0.04046725073007922,"floatShares":258000000,"shares":6637000000,"eps":1.3762966621200003,"marketStatus":"Trading","change":-1.94,"latestTime":"08-31 14:22:59","open":47.94,"high":47.94,"low":45.74,"amount":174189795,"amplitude":0.045891,"askPrice":46.02,"askSize":1200,"bidPrice":46,"bidSize":200,"shortable":3,"etf":0,"ttmEps":1.3572734430020534,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788163800000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":47.94,"dividendRate":0.005073,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.568554,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":46.04,"timestamp":1788157377000,"preClose":47.32,"halted":0,"volume":73806800,"delay":0,"premium":"-14.34"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.376297,"volumeRatio":0.568554,"shares":6637000000,"dividePrice":0.233271,"high":47.94,"amplitude":0.045891,"preClose":47.94,"low":45.74,"week52Low":45.66,"pbRate":"4.06","psRate":"8.36","week52High":94.869,"institutionHeld":0,"latestPrice":46,"committee":-0.714286,"eps":1.3762966621200003,"divideRate":0.005071,"volume":3758650,"delay":0,"ttmEps":1.3572734430020534,"open":47.94,"prevYearClose":71.002,"prevWeekClose":47.94,"prevMonthClose":57.1,"prevQuarterClose":57.85,"fiveDayClose":46.46,"twentyDayClose":56.7,"sixtyDayClose":53.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-08-28","current":33.891476,"percent":0.073482,"low":37.44534,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"high":65.582363,"avg":51.608247,"sd":7.143718,"marketCap":363468645736.13},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13}],"updateTime":1788157379613},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148990473","title":"Movement Alert｜HENGRUI PHARMA Falls 8.55% in Regular Trading, H1 Revenue Declines as Core Profit Drops 12.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148990473","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148990473?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:33","pubTimestamp":1787189623,"startTime":"0","endTime":"0","summary":"On August 20, HENGRUI PHARMA fell 8.55% in regular trading, trading at HK$50.85/share, with turnover of HK$109 million. The selloff was triggered by the company's disappointing first-half earnings...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HENGRUI PHARMA Falls as H1 Revenue Declines as Core Profit Drops 12.7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171904948","title":"Hengrui Pharma Announces Resignation of Joint Company Secretary Liu Xiaohan","url":"https://stock-news.laohu8.com/highlight/detail?id=1171904948","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171904948?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:29","pubTimestamp":1787149741,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”) disclosed that Ms. Liu Xiaohan resigned from her position as joint company secretary, effective 19 August 2026. According to the board,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185153566","title":"Hengrui Pharma Appoints Tian Fei as New Board Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1185153566","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185153566?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:22","pubTimestamp":1787149332,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has announced a key executive change, with the appointment of Tian Fei as the company's new Board Secretary.The decision was formally ratified during the fourth meeting of the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997244956.HKD","LU1146622755.USD","LU2543165471.USD","LU2097828714.EUR","BK0239","LU2289578879.USD","LU2097828805.USD","LU2580892862.HKD","BK0012","BK0188","LU2328871848.SGD","BK0028","LU1781817850.SGD","BK1191","LU1969619763.USD","LU1064130708.USD","LU1023057109.AUD","LU0405327494.USD","LU1255011170.USD","LU1580142542.USD","LU1328615791.USD","LU1997245177.USD","LU2097828474.EUR","LU1820825898.SGD","LU2495084118.USD","BK0183","LU1064131003.USD","LU2097828631.EUR","600276","BK0060","LU2580892789.USD","LU0359201885.HKD","LU0359202008.SGD","LU0359201612.USD","LU1997245094.SGD","LU2097828557.USD","LU2148510915.USD","LU2488822045.USD","LU1655091616.SGD","BK0196","LU0405327148.USD","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139277418","title":"HENGRUI PHARMA Proposes New H-Share Incentive Scheme for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1139277418","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139277418?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:52","pubTimestamp":1787147541,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) announced that on August 19, 2026, its board has resolved to recommend the adoption of the 2026 H-Share Share Plan.The plan will take effect upon approval at the upcoming first extraordinary general meeting of the company in 2026.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","LU1820825898.SGD","LU1064131003.USD","BK0188","01276","LU1023057109.AUD","LU0359201885.HKD","LU1969619763.USD","LU2148510915.USD","LU1655091616.SGD","LU1146622755.USD","LU2495084118.USD","LU2097828805.USD","LU2097828714.EUR","LU2097828557.USD","LU0405327494.USD","BK0239","LU0405327148.USD","BK1191","LU1255011170.USD","LU1997244956.HKD","LU2488822045.USD","BK0028","LU2580892862.HKD","LU1328615791.USD","LU2289578879.USD","LU2580892789.USD","LU2097828631.EUR","LU0359202008.SGD","LU1781817850.SGD","LU2097828474.EUR","LU1064130708.USD","600276","LU2543165471.USD","LU1997245094.SGD","LU1997245177.USD","BK0012","LU2328871848.SGD","BK0060","BK0183","BK0196","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196895712","title":"Hengrui Pharma Maintains H1 2026 Profitability; Innovative Drug Sales Rise 16.4% Despite Flat Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1196895712","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196895712?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:46","pubTimestamp":1787147187,"startTime":"0","endTime":"0","summary":"Hengrui Pharma reported first-half 2026 revenue of RMB 15.46 billion, edging down 1.9% year on year as lower licensing receipts offset higher product sales. Gross profit slipped 2.2% to RMB 13.34...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hengrui Pharma Maintains H1 2026 Profitability; Innovative Drug Sales Rise 16.4% Despite Flat Revenue","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100417660","title":"Hengrui Pharma Unveils 2026 A-Share Employee Stock Ownership Plan Valued at Approx. RMB 0.34 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1100417660","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100417660?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:46","pubTimestamp":1787147163,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has approved a new 2026 A-share Employee Stock Ownership Scheme (ESOS), pending shareholder approval at an upcoming extraordinary general...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178000037","title":"Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1178000037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178000037?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:08","pubTimestamp":1787141307,"startTime":"0","endTime":"0","summary":"On August 19, Hengrui Pharma (01276) released its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 15.456 billion, with product sales revenue of RMB...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0060","LU1997244956.HKD","LU2488822045.USD","BK1191","LU1997245094.SGD","LU1023057109.AUD","LU0405327494.USD","LU1997245177.USD","BK0183","LU2097828714.EUR","MEDX","BK0239","LU1146622755.USD","LU2097828631.EUR","LU2097828557.USD","LU0405327148.USD","01276","BK1574","BK0028","LU1969619763.USD","LU0359201885.HKD","LU1255011170.USD","LU1781817850.SGD","159992","LU2328871848.SGD","LU2289578879.USD","LU2543165471.USD","LNGR","BK0196","LU1580142542.USD","06978","BK0188","LU2148510915.USD","IBBQ","LU1064131003.USD","LU2580892862.HKD","LU2580892789.USD","LU0359202008.SGD","600276","LU1820825898.SGD","LU2097828474.EUR","LU2495084118.USD","LU1328615791.USD","LU2097828805.USD","LU1064130708.USD","LU0359201612.USD","LU1655091616.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170305883","title":"HENGRUI PHARMA: Wellington Management Group LLP Disposes of Shares, Long Position Falls to 5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170305883","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170305883?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:12","pubTimestamp":1787130761,"startTime":"0","endTime":"0","summary":"On August 14, 2026, Wellington Management Group LLP sold 1.07 million shares of HENGRUI PHARMA (H shares) at an average of HKD 52.7484 per share, involving about HKD 56.20 million.Prior to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170866253","title":"AH Share Premium Rankings: August 19 Market Close Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=1170866253","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170866253?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:16","pubTimestamp":1787127414,"startTime":"0","endTime":"0","summary":"Data from the August 19 market close reveals notable shifts in the A-H share premium landscape. NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and ANDRE JUICE (02218) hold the top three positions for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02865","BK1551","HK0000151867.HKD","LU0831093199.SGD","LU0165289439.USD","LU0181495838.USD","LU0819123356.HKD","LU0828237940.HKD","LU2778985437.USD","BK1214","LU0269904917.USD","LU0455707207.USD","LU1242518857.USD","BK1193","HK0001040143.USD","LU0823426480.USD","LU0634319403.HKD","LU0918141705.HKD","LU0235996351.USD","BK1183","03200","LU0149721374.USD","LU0164872284.USD","LU0210527791.USD","LU2097828557.USD","LU0348735423.USD","BK1560","LU0117841782.USD","LU0672654166.SGD","LU0370786039.SGD","LU1048588211.SGD","LU0315178854.USD","IE00B0169L03.USD","LU0128522157.USD","LU1642822792.SGD","LU0862451753.SGD","LU0737861699.HKD","LU0096374516.USD","02715","LU0431992006.USD","LU0164865239.USD","HK0000352291.HKD","LU1880383366.USD","LU1961090484.USD","LU0106959298.USD","BK1546","03968","LU0640798160.USD","LU0244354667.USD","LU2543165471.USD","LU0163747925.USD","LU2348774022.SGD","LU2242644610.SGD","LU1366334578.USD","LU2177674079.SGD","00300","LU0605514214.HKD","LU0831103253.SGD","BK1190","LU0594300179.USD","LU0348783662.USD","LU0315179316.USD","IE00BVYPNQ40.USD","82318","LU2348773727.SGD","LU0228367735.SGD","LU1720050803.USD","LU0164880469.USD","LU0828238088.HKD","LU0314109678.HKD","LU1808992512.USD","LU1244550221.USD","BK1249","BK1163","LU0417516738.SGD","LU2264538146.SGD","IE0008368742.USD","IE0034224299.USD","LU0359201612.USD","LU0823426308.USD","LU0345780281.USD","BK1550","LU1981816686.USD","01377","LU0737861772.HKD","SG9999002463.SGD","LU1794554557.SGD","IE0008369823.USD","BK1526","HK0000306701.USD","LU0328353924.USD","LU2045819591.USD","HPAD.SI","LU1046422090.SGD","IE00B031J352.USD","LU0228659784.USD","02846","LU0084288322.USD","LU2294711473.HKD","LU0588545904.SGD","BK1513","LU0516422952.EUR","EWH","02338","LU0588545730.USD","LU1044874839.SGD","LU1051768304.USD","LU0048580855.USD","LU0828237510.HKD","LU1688375341.USD","LU1211504680.USD","BK1186","LU1675838814.USD","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1008478684.HKD","LU0359201885.HKD","LU1105468828.SGD","BK1533","LU0821914370.USD","LU0106252389.USD","LU2476274308.USD","LU0449509016.USD","LU1515016050.SGD","LU0594300419.USD","LU1820825898.SGD","BK1191","BK1544","LU0052750758.USD","BK1521","SG9999006597.SGD","LU0164939612.USD","LU0320764755.SGD","LU0049112450.USD","03308","LU0898667661.SGD","03268","IE00BMCWC346.EUR","LU0348788117.USD","LU0469268626.HKD","01276","LU3063872942.SGD","BK1576","LU1807302812.USD","03130","LU2293587155.HKD","LU0882747503.HKD","LU0572944931.SGD","LU0307460666.USD","LU0651946864.USD","BK1184","LU0762542818.HKD","LU1508157978.USD","BK1147","LU1224709979.USD","IE00BGHQDM52.EUR","01812","HK0000306685.HKD","LU1044875133.USD","HK0000320223.HKD","IE00B29SXG58.USD","LU0029875118.USD","LU0797268264.HKD","LU1146622755.USD","LU0449515922.USD","BK1105","03143","LU0516423174.USD","02691","LU1051769294.HKD","IE0003895053.USD","LU0607220059.USD","LU0051755006.USD","LU0918141887.USD","LU0762541174.USD","PAImain","LU2152927971.USD","LU0061477393.USD","LU2097828805.USD","LU1282649141.HKD","IE00B543WZ88.USD","HK0000352382.USD","LU0531970944.HKD","LU1152091754.HKD","LU2153592121.USD","LU0543330566.HKD","LU0214875030.USD","00187","LU0868486357.SGD","BK1583","LU1328277881.USD","LU0266512127.USD","LU0287142896.SGD","LU0456846285.SGD","LU1115378108.SGD","SG9999000459.SGD","LU1655091459.SGD","LU0509642566.USD","LU0196878994.USD","LU0531971595.HKD","LU1048596156.SGD","LU1023057109.AUD","LU1282651121.HKD","LU2008162690.USD","LU0210526637.USD","BK1514","LU0543330483.HKD","LU1769817179.HKD","IE00BZ08YR35.GBP","83188","LU0611395673.USD","BK1149","LU0651947912.USD","LU0348825331.USD","LU0266512473.USD","LU1152091168.USD","LU0348766576.USD","LU1226287529.USD","IE00BZ08YT58.USD","LU0890818403.SGD","LU1282649067.USD","02701","399300","LU0441854154.USD","BK1141","LU0039217434.USD","LU2097828474.EUR","LU0456854461.SGD","LU1719994722.HKD","LU0054450605.USD","LU0067412154.USD","03145","BK1240","LU1064131342.USD","01776","BK1122","LU0117844026.USD","LU0456827905.SGD","159982","LU0359202008.SGD","LU0149534421.HKD","LU0589944569.HKD","LU0348784397.USD","LU2039709279.SGD","LU0871576103.HKD","LU0293314216.USD","00317","LU0865486749.SGD","BK1567","LU0791590937.USD","LU1235295612.USD","LU2663582299.SGD","01108","00042","BK1231","LU1993786604.SGD","BK1116","BK1185","LU0417516902.SGD","SG9999001903.USD","LU0254981946.USD","LU0516422440.USD","02359","02218","03986","LU0384037296.USD","01033","LU0979878070.USD","LU0630378429.USD","LU1960683339.HKD","LU0329678170.USD","LU0588545490.SGD","LU0886674414.USD","LU1481107354.HKD","LU2097828714.EUR","LU1224444064.USD","LU2125910500.SGD","LU0501845795.SGD","LU1880383440.USD","LU0488056044.USD","00553","LU0516423091.SGD","LU0348816934.USD","BK1594","SG9999002562.SGD","LU0540923850.HKD","BK1507","LU0791591158.USD","LU0348805143.USD","LU1242518931.SGD","LU0502904849.HKD","LU0784639295.USD","02208","LU0082770016.USD","LU1044876610.USD","SG9999014674.SGD","PNGAY","07233","LU0348814723.USD","BK1170","HK0000286598.CNH","LU0878004406.USD","LU0049853897.USD","LU1303224171.USD","LU1770034418.SGD","06951","82846","IE0031814852.USD","LU0348783233.USD","LU0819121731.USD","IE00BVYPNP33.GBP","BK1110","LU0327786744.USD","LU0011963245.USD","LU1988902786.USD","LU2424517915.HKD","LU0211977185.USD","LU2226246903.HKD","BK1564","SG9999011746.SGD","03759","LU1251922891.USD","LU2153591404.USD","BK1522","BK1610","LU1282648689.USD","601318","SG9999004220.SGD","BK1198","LU0231483743.USD","IE00BF5LJ272.USD","02475","LU0648948544.HKD","LU0348827113.USD","LU0856984785.SGD","LU0140636845.USD","LU0588546209.SGD","BK1171","LU1282651048.USD","LU0630378692.HKD","01349","LU0593848301.USD","LU0072462343.USD","BK1144","IE00B031HY20.USD","LU1188198961.HKD","IE00BZ08YS42.EUR","LU0561508036.HKD","LU1504937902.USD","LU0173614495.USD","83130","LU0417516571.SGD","LU0463099449.HKD","03678","LU0762540952.USD","HK0000320264.USD","LU0043850808.USD","LU2476274720.SGD","02318","BK1237","02827","LU1244550494.USD","LU0620787316.HKD","IE0032431581.USD","BK1205","LU1813983027.USD","BK1505","BK1592","BK1554","BK1558","BK1562","HK0001040168.HKD","LU2399975544.HKD","00668","03188","LU0345780521.USD","01057","LU0197773673.USD","00995","LU0329678337.USD","LU0197773160.USD","LU0650527681.SGD","LU0320764599.SGD","LU0516422366.SGD","LU0675040207.SGD","IE00B3M56506.USD","02768","LU2097828631.EUR","LU0072913022.USD","IE00BYV24P56.USD","LU1244550577.SGD","SG9999002828.SGD","LU1282649810.SGD","LU0229945570.USD","LU0880133367.SGD","LU1769817096.USD","02899","LU1366334651.USD","LU0082770016.SGD","BK1202","BK1223","LU1831875114.USD","LU0862451837.USD","LU0878005551.USD","LU0348767384.USD","LU0708995583.HKD","SG9999001093.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109339300","title":"Movement Alert｜HENGRUI PHARMA Falls 3.19% in Regular Trading, Cautious Earnings Outlook and Sector Weakness Weigh on Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1109339300","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109339300?lang=en_us&edition=fundamental","pubTime":"2026-08-14 09:40","pubTimestamp":1786671632,"startTime":"0","endTime":"0","summary":"On August 14, HENGRUI PHARMA fell 3.19% in regular trading, trading at 53.3 HKD/share, with turnover of approximately 49.84 million HKD.The decline comes ahead of the company's interim results...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659213182","title":"Hengrui Pharma Gets China Nod For Inflammatory Bowel Injection Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659213182","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659213182?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:27","pubTimestamp":1786588055,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  has received approval from China's National Medical Products Administration to carry out clinical trials for its therapeutic biological product, SHR-7590 Injection.The injection is indicated for the treatment of inflammatory bowel diseases, ulcerative colitis and Crohn's disease, according to a Shanghai Stock Exchange filing on Thursday.The company has so far invested 32.5 million yuan in the research and development of the injection.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0405327148.USD","LU2148510915.USD","LU1146622755.USD","LU2289578879.USD","LU1997245094.SGD","LU1820825898.SGD","LU2097828474.EUR","LU2097828714.EUR","BK0188","LU1023057109.AUD","LU1580142542.USD","LU1997245177.USD","LU1064130708.USD","BK1191","LU0359201612.USD","01276","LU0405327494.USD","LU1255011170.USD","LU1969619763.USD","BK0183","LU1655091616.SGD","LU2097828557.USD","LU2495084118.USD","LU2580892789.USD","LU2580892862.HKD","BK0196","LU2097828631.EUR","LU1064131003.USD","LU1997244956.HKD","LU0359201885.HKD","LU0359202008.SGD","LU1328615791.USD","BK0028","LU2543165471.USD","600276","BK0012","BK0239","LU2097828805.USD","LU2328871848.SGD","BK0060","LU1781817850.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659824561","title":"Hengrui Pharma Gets China Nod For Phase II Diabetes Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659824561","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659824561?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:21","pubTimestamp":1786587667,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  has received approval from China's National Medical Products Administration to conduct a Phase II clinical trial for its HRS-4729 injection in adult patients with type 2 diabetes.The drug is a triple agonist targeting GLP-1R, GIPR, and GCGR receptors, designed to improve glucose metabolism, aid weight loss, and suppress appetite.The company is already conducting a separate Phase II trial for the drug as a weight-loss treatment, according to a Shanghai Stock Exchange filing on Thursday.The company has invested about 81.6 million yuan in the research and development of the injection to date.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01276","LU2580892789.USD","LU1997245094.SGD","BK0188","LU1820825898.SGD","BK0060","LU1781817850.SGD","BK0183","LU2328871848.SGD","LU1328615791.USD","LU2097828631.EUR","LU1580142542.USD","LU1997244956.HKD","BK0196","LU0405327494.USD","BK1191","LU2580892862.HKD","LU0359201612.USD","LU1146622755.USD","LU1064130708.USD","LU2097828714.EUR","LU2148510915.USD","BK0239","600276","BK0028","LU2097828805.USD","LU2488822045.USD","LU1064131003.USD","LU2495084118.USD","LU1023057109.AUD","LU1655091616.SGD","BK0012","LU1969619763.USD","LU0359202008.SGD","LU0405327148.USD","LU2543165471.USD","LU2097828557.USD","LU2097828474.EUR","LU1997245177.USD","LU2289578879.USD","LU1255011170.USD","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114062740","title":"Hengrui Pharma Repurchases 0.002% of Share Capital, Adds 0.13 Million Shares to Treasury","url":"https://stock-news.laohu8.com/highlight/detail?id=1114062740","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114062740?lang=en_us&edition=fundamental","pubTime":"2026-08-12 17:06","pubTimestamp":1786525567,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed on 12 August 2026 that it repurchased 125,000 A-shares on the Shanghai Stock Exchange for its Employee Stock Ownership Schemes. • Transaction size...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140765855","title":"Hengrui Pharma Spends 6.79 Million Yuan on Share Buyback on August 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1140765855","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140765855?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:50","pubTimestamp":1786524614,"startTime":"0","endTime":"0","summary":"On August 12, 2026, Hengrui Pharma (01276) utilized 6.794 million yuan to repurchase 125,000 A-shares. The buyback price per share ranged between 54.15 yuan and 54.41 yuan.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1146622755.USD","LU1781817850.SGD","LU1997244956.HKD","LU2097828805.USD","LU2488822045.USD","LU1997245177.USD","LU2097828714.EUR","LU2148510915.USD","BK0012","LU1064130708.USD","159982","BK0183","LU2289578879.USD","LU1580142542.USD","LU0359201885.HKD","LU0359201612.USD","BK0196","LU1255011170.USD","LU2543165471.USD","LU2097828474.EUR","LU0405327148.USD","LU2328871848.SGD","600276","LU2495084118.USD","BK0028","BK0188","399300","LU1328615791.USD","LU2580892862.HKD","BK1191","LU1820825898.SGD","LU1997245094.SGD","LU2097828631.EUR","LU2580892789.USD","01276","LU0405327494.USD","LU2097828557.USD","LU1655091616.SGD","BK0239","LU1023057109.AUD","LU1969619763.USD","BK0060","LU1064131003.USD","LU0359202008.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108479803","title":"Jiangsu Hengrui Pharma Secures Clinical Trial Approval for Innovative Multi-Peptide Drug HRS-4729 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1108479803","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108479803?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:44","pubTimestamp":1786524272,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SHA: 600276) has announced receiving the Drug Clinical Trial Approval Notice from the National Medical Products Administration (NMPA) for its HRS-4729...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327148.USD","LU0359201885.HKD","LU1820825898.SGD","LU2289578879.USD","LU2580892862.HKD","01276","LU2488822045.USD","LU2097828474.EUR","LU2097828631.EUR","LU2097828714.EUR","BK0239","BK0028","LU1146622755.USD","IBBJ","LU0359202008.SGD","LU2097828805.USD","LU1655091616.SGD","LU2148510915.USD","LU2580892789.USD","BK0188","LU1328615791.USD","BMED","IBBQ","LU1781817850.SGD","BK0012","LU2543165471.USD","MDTX","600276","BK0196","LU2097828557.USD","LU0359201612.USD","LU2495084118.USD","BK1191","LU0405327494.USD","LU1969619763.USD","BK0060","LU2328871848.SGD","LU1023057109.AUD","LU1997245177.USD","LU1580142542.USD","BK0183","LU1997244956.HKD","LU1255011170.USD","LU1997245094.SGD","PSYK","LU1064131003.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180135180","title":"Earning Preview: HENGRUI PHARMA Q2 revenue is expected to increase, and institutional views are cautiously optimistic","url":"https://stock-news.laohu8.com/highlight/detail?id=1180135180","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180135180?lang=en_us&edition=fundamental","pubTime":"2026-08-12 09:51","pubTimestamp":1786499503,"startTime":"0","endTime":"0","summary":"Abstract HENGRUI PHARMA will report results on August 19, 2026, post-Market; this preview compiles the latest quarter’s performance and consensus expectations, focusing on revenue, margins, EPS...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: HENGRUI PHARMA Q2 revenue is expected to increase, and institutional views are cautiously optimistic","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132656558","title":"HENGRUI PHARMA: Wellington Management Group LLP Disposes of Shares, Long Position Falls to 6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132656558","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132656558?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:15","pubTimestamp":1786439716,"startTime":"0","endTime":"0","summary":"Wellington Management Group LLP sold 508,285 shares of HENGRUI PHARMA stock at an average of HKD 58.3601 per share on August 10, 2026, involving about HKD 29.66 million.Prior to the disposal,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137013945","title":"Hengrui Pharma's NewCo Partner Debuts on Nasdaq Following Kailera","url":"https://stock-news.laohu8.com/highlight/detail?id=1137013945","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137013945?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:12","pubTimestamp":1786363960,"startTime":"0","endTime":"0","summary":"Hengrui Pharma announced on August 9 that its partner, Braveheart Bio, successfully listed on the Nasdaq on August 6 local time. The IPO raised approximately $439.9 million, including the full...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997244956.HKD","LU2580892862.HKD","LU1969619763.USD","LU2097828474.EUR","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2580892789.USD","IE00BGHQF748.EUR","LU2097828557.USD","SG9999014021.USD","600276","LU2095319765.USD","BK4585","LU2148510915.USD","NDAQ","LU0405327494.USD","SG9999014013.SGD","LU2097828631.EUR","SG9999014005.SGD","LU1064131003.USD","IE00B3QW5Z07.USD","BK4112","BK0012","LU1328615791.USD","LU2097828714.EUR","LU2210149790.SGD","01276","BK0183","LU2495084118.USD","LU1997245177.USD","BCDF","BK0188","LU1997245094.SGD","BK0060","LU2488822045.USD","BK0239","IE00BN0W2T93.GBP","BK0196","LU2097828805.USD","LU2328871848.SGD","LU1064130708.USD","IE00B64PRP62.GBP","LU1655091616.SGD","LU1255011170.USD","BK0028","BK4588","LU1146622755.USD","LU1580142542.USD","LU0405327148.USD","LU1820825898.SGD","LU1781817850.SGD","LU2210150020.SGD","LU2289578879.USD","LU0314104364.USD","SG9999014039.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169979764","title":"AH Share Premium Ranking Summary for August 10","url":"https://stock-news.laohu8.com/highlight/detail?id=1169979764","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169979764?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:25","pubTimestamp":1786350306,"startTime":"0","endTime":"0","summary":"As of the close on August 10, the top three positions in the AH premium ranking were held by NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033), with premium rates of 1011.11%,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0871576103.HKD","LU0049853897.USD","LU0072913022.USD","02768","LU0314109678.HKD","LU0328353924.USD","LU1981816686.USD","LU1366334651.USD","LU1282649810.SGD","BK1514","LU1481107354.HKD","BK1170","00991","HK0000151867.HKD","LU0214875030.USD","BK1223","LU0868486357.SGD","IE00BZ08YR35.GBP","IE0032431581.USD","IE00B0169L03.USD","SG9999006597.SGD","LU0648948544.HKD","03308","HK0000306685.HKD","LU0348767384.USD","LU0320764755.SGD","06613","SG9999002562.SGD","IE0031814852.USD","LU0029875118.USD","LU1188198961.HKD","03678","SG9999011746.SGD","LU0516422440.USD","LU0449515922.USD","LU1719994722.HKD","LU0384037296.USD","LU1251922891.USD","LU0039217434.USD","LU0163747925.USD","LU0708995583.HKD","LU0572944931.SGD","HK0001040143.USD","LU0348783662.USD","BK1149","BK1191","BK1583","LU1880383366.USD","LU0084288322.USD","LU1328277881.USD","LU1794554557.SGD","LU1115378108.SGD","02208","LU1303224171.USD","LU0531971595.HKD","LU1224709979.USD","LU0051755006.USD","01688","LU0359201885.HKD","LU0823426480.USD","02359","LU1008478684.HKD","BK1105","BK1607","BK1576","LU1282649141.HKD","03968","LU2543165471.USD","LU0348814723.USD","LU1282648689.USD","LU2226246903.HKD","IE0008368742.USD","LU0054450605.USD","LU1807302812.USD","LU0702159343.USD","03145","LU2045819591.USD","LU2039709279.SGD","LU2348773727.SGD","LU0348735423.USD","LU2424517915.HKD","BK1594","LU0791590937.USD","BK1202","LU0823426308.USD","03759","LU0348784397.USD","LU0228367735.SGD","LU0117841782.USD","LU0862451837.USD","LU0898667661.SGD","LU0516422952.EUR","LU0630378692.HKD","LU1044875133.USD","IE00BVYPNQ40.USD","LU0702159699.USD","BK1550","LU0456846285.SGD","LU0455707207.USD","03200","BK1541","LU1244550494.USD","LU0594300419.USD","BK1513","BK1240","LU0181495838.USD","01349","BK1502","LU1044874839.SGD","LU0797268264.HKD","LU0878004406.USD","LU0831093199.SGD","LU0348783233.USD","SG9999001903.USD","LU0819123356.HKD","LU0540923850.HKD","00598","LU0173614495.USD","LU1046422090.SGD","LU0359202008.SGD","HK0000500386.USD","LU2476274720.SGD","LU0210526637.USD","LU1770034418.SGD","LU0630378429.USD","LU0320764599.SGD","BK1562","LU0197773673.USD","BK1205","06745","LU1051769294.HKD","BK1551","HK0000286598.CNH","LU1688375341.USD","LU0049112450.USD","SG9999002463.SGD","BK1558","LU1023057109.AUD","00042","LU1242518931.SGD","LU0828237940.HKD","BK1535","LU0449509016.USD","HPAD.SI","LU1282651121.HKD","LU0588545904.SGD","LU0634319403.HKD","LU0228659784.USD","IE00BGHQDM52.EUR","BK1521","01812","LU0589944569.HKD","LU0561508036.HKD","00916","LU0588545730.USD","HK0001040168.HKD","399300","LU0918141887.USD","LU2476274308.USD","LU0918141705.HKD","LU0823040885.USD","LU0882747503.HKD","IE00BZ08YT58.USD","LU0880133367.SGD","IE00BVYPNP33.GBP","LU0072462343.USD","LU0128522157.USD","BK1171","LU1642822792.SGD","LU0469268626.HKD","LU0784639295.USD","LU1831875114.USD","LU0052750758.USD","LU0315179316.USD","LU0164880469.USD","LU0890818403.SGD","LU0441854154.USD","HK0000352382.USD","LU0011963245.USD","LU1048596156.SGD","LU2778985437.USD","PAImain","LU0348825331.USD","02691","LU1152091168.USD","01057","LU1152091754.HKD","LU1769817096.USD","LU1224444064.USD","01033","LU0501845795.SGD","00300","LU1244550221.USD","00568","BK1610","02318","IE00BZ08YS42.EUR","BK1141","00763","LU1242518857.USD","LU1769817179.HKD","02865","HK0000252160.HKD","03750","LU2153591404.USD","LU0456827905.SGD","LU0543330566.HKD","LU0650527681.SGD","LU0235996351.USD","LU1993786604.SGD","LU1960683339.HKD","LU0348766576.USD","LU0165289439.USD","LU0605514214.HKD","LU1146622755.USD","BK1135","LU1655091459.SGD","LU0106959298.USD","LU0463099449.HKD","BK1526","LU0675040207.SGD","LU1366334578.USD","LU1235295612.USD","LU1820825898.SGD","LU0348816934.USD","HK0000306701.USD","LU0819121731.USD","03986","LU0856984785.SGD","LU0315178854.USD","LU1808992512.USD","LU1720050803.USD","LU0588545490.SGD","LU1961090484.USD","BK1183","02475","BK1231","LU0164872284.USD","LU0348805143.USD","LU0593848301.USD","LU1880383440.USD","HK0000320264.USD","01108","LU0516422366.SGD","BK1506","LU2152927971.USD","LU0543330483.HKD","BK1116","BK1237","LU0149534421.HKD","SG9999014674.SGD","LU0117844026.USD","LU1515016050.SGD","LU0307460666.USD","BK1546","BK1505","IE00B5MMRT66.SGD","LU0516423174.USD","LU0762540952.USD","LU0164865239.USD","LU2153592121.USD","LU0359201612.USD","LU1048588211.SGD","03143","LU0106252389.USD","LU0821914370.USD","02218","LU0327786744.USD","LU0607220059.USD","BK1154","BK1214","LU1282649067.USD","LU1244550577.SGD","BK1564","02338","LU0865486749.SGD","IE00B29SXG58.USD","LU0531970944.HKD","BK1147","HK0000252152.HKD","LU0828237510.HKD","LU2293587155.HKD","BK1122","LU0254981946.USD","BK1163","LU0640798160.USD","LU2294711473.HKD","LU1044876610.USD","IE00B543WZ88.USD","LU0293314216.USD","LU0831103253.SGD","82318","IE00B3M56506.USD","LU0502904849.HKD","LU0611395673.USD","LU0229945570.USD","LU2399975544.HKD","159982","HK0000352291.HKD","LU0979878070.USD","BK1125","BK1144","LU0672654166.SGD","LU0417516571.SGD","PNGAY","LU0210527791.USD","LU1813983027.USD","LU0197773160.USD","BK1560","BK1184","BK1151","LU1105468828.SGD","LU0370786039.SGD","01276","LU0287142896.SGD","BK1529","SG9999004220.SGD","LU0594300179.USD","LU0244354667.USD","BK1522","00553","LU0431992006.USD","LU0348788117.USD","IE00BMCWC346.EUR","LU1211504680.USD","LU2348774022.SGD","IE00B031J352.USD","BK1554","LU1226287529.USD","BK1507","HK0000320223.HKD","LU0516423091.SGD","LU0791591158.USD","LU0878005551.USD","IE0008369823.USD","LU0048580855.USD","EWH","02465","LU0348827113.USD","LU0651946864.USD","LU0488056044.USD","LU0762542818.HKD","LU1675838814.USD","LU0149721374.USD","LU2242644610.SGD","LU1051768304.USD","IE00B031HY20.USD","LU0588546209.SGD","LU0196878994.USD","BK1110","LU0417516738.SGD","LU0651947912.USD","SG9999002828.SGD","LU0862451753.SGD","IE0003895053.USD","BK1533","LU0211977185.USD","IE00BYV24P56.USD","LU0417516902.SGD","LU0762541174.USD","LU0140636845.USD","BK1249","IE00BF5LJ272.USD","LU0043850808.USD","06655","LU0326950275.SGD","SG9999000459.SGD","LU1282651048.USD","LU2125910500.SGD","IE0034224299.USD","601318","LU0067412154.USD","LU0231483743.USD","LU0737861699.HKD","BK1530","LU1166156734.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658010276","title":"Hengrui Pharma Gets Nod to Add Fifth Indication for Ivarmacitinib Sulfate Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658010276","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658010276?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:08","pubTimestamp":1786331317,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  received approval from China's National Medical Products Administration to add a fifth indication for its ivarmacitinib sulfate tablets or SHR0302 tablets, according to a weekend disclosure on the Hong Kong bourse.The pharmaceutical company's shares rose 1% during Monday's morning trade.The regulator approved the drug as a treatment for adult patients with active nonradiographic axial spondyloarthritis, who have had an inadequate response or intolerance to nonsteroidal anti-inflammatory drugs and who have objective signs of inflammation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01276","LU1064130708.USD","LU1655091616.SGD","BK0028","LU0359202008.SGD","LU2495084118.USD","LU2097828805.USD","LU0405327148.USD","600276","LU1820825898.SGD","LU2097828631.EUR","LU2289578879.USD","BK0183","LU1023057109.AUD","BK0060","LU1580142542.USD","LU2097828714.EUR","LU1064131003.USD","BK0188","LU1255011170.USD","LU1997245094.SGD","LU1781817850.SGD","LU2148510915.USD","LU2097828557.USD","LU0405327494.USD","LU1328615791.USD","LU0359201885.HKD","LU2543165471.USD","LU2488822045.USD","LU2580892862.HKD","BK0239","LU2580892789.USD","BK0012","BK0196","LU1997245177.USD","LU1969619763.USD","LU2328871848.SGD","BK1191","LU0359201612.USD","LU1997244956.HKD","LU1146622755.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}